These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13698702)

  • 1. Studies on the mechanism of immunological enhancement of tumor grafts.
    FELDMAN M; GLOBERSON A
    J Natl Cancer Inst; 1960 Sep; 25():631-48. PubMed ID: 13698702
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological enhancement of tumor homografts in mice: a review.
    KALISS N
    Cancer Res; 1958 Oct; 18(9):992-1003. PubMed ID: 13596939
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors determining homograft destruction and immunological enhancement in mice receiving successive tumor inocula.
    KALISS N; BRYANT BF
    J Natl Cancer Inst; 1958 Apr; 20(4):691-704. PubMed ID: 13539618
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological and electrophoretic studies of human tissue and tumor antigens.
    KORNGOLD L; VAN LEEUWEN G
    Cancer Res; 1957 Sep; 17(8):775-9. PubMed ID: 13460982
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relationship between immunological defence and the development of tumours].
    Leone G
    Arch Sci Med (Torino); 1973; 130(4):273-82. PubMed ID: 17343168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor escape mechanism governed by myeloid-derived suppressor cells.
    Nagaraj S; Gabrilovich DI
    Cancer Res; 2008 Apr; 68(8):2561-3. PubMed ID: 18413722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological tolerance in tumor transplants.
    KOPROWSKI H
    Fed Proc; 1957 Jul; 16(2):592-600. PubMed ID: 13461928
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic response of cancer under the influence of immunological activity and therapy.
    de Vladar HP; González JA
    J Theor Biol; 2004 Apr; 227(3):335-48. PubMed ID: 15019501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on antigenic properties heterologous cancer grafts].
    STEPINA VN
    Vopr Onkol; 1959; 5(4):398-401. PubMed ID: 13659894
    [No Abstract]   [Full Text] [Related]  

  • 11. Polarization of endosomal SNX27 in migrating and tumor-engaged natural killer cells.
    MacNeil AJ; Pohajdak B
    Biochem Biophys Res Commun; 2007 Sep; 361(1):146-50. PubMed ID: 17644068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of tumor allergy and its importance in tumor pathogenesis].
    BERDEL W; NASS G; WIEDEMANN G
    Int Arch Allergy Appl Immunol; 1956; 9(3-4):200-21. PubMed ID: 13398156
    [No Abstract]   [Full Text] [Related]  

  • 13. LIGHTing the way for tumor immunity.
    Houghton AN
    Nat Immunol; 2004 Feb; 5(2):123-4. PubMed ID: 14749779
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the impact of pro- and antiinflammatory immune processes at the two immune-deviated sites, eye and solid tumor and possible consequences for the antitumoral therapy with fever inducers.
    Schramm H
    Forsch Komplementarmed Klass Naturheilkd; 2005 Feb; 12(1):37-46. PubMed ID: 15772461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to therapeutic cancer vaccines.
    Hellstrom KE; Hellstrom I
    Expert Rev Vaccines; 2003 Aug; 2(4):517-32. PubMed ID: 14711336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
    Munn DH
    Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STUDIES ON THE MECHANISM RESPONSIBLE FOR THE SPONTANEOUS REGRESSION OF THE SHOPE RABBIT PAPILLOMA.
    KREIDER JW
    Cancer Res; 1963 Oct; 23():1593-9. PubMed ID: 14072700
    [No Abstract]   [Full Text] [Related]  

  • 18. Delay-induced model for tumor-immune interaction and control of malignant tumor growth.
    Banerjee S; Sarkar RR
    Biosystems; 2008 Jan; 91(1):268-88. PubMed ID: 18083299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes and the MICA-NKG2D system in cancer.
    Clayton A; Tabi Z
    Blood Cells Mol Dis; 2005; 34(3):206-13. PubMed ID: 15885603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-review: overcoming tumor-intrinsic resistance to immune effector function.
    Ganss R; Arnold B; Hämmerling GJ
    Eur J Immunol; 2004 Oct; 34(10):2635-41. PubMed ID: 15368278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.